Anavex Life Sciences Corp (AVXL)

[falconer66a]

The Science Is Good, The Company Will Be

I continue to hold my moderate AVXL position; won’t be selling any of it any time soon. Should Anavex tank (won’t happen, too many solid, diverse assets), I’d just write off the loss. I’m no fool. Have invested only what I can afford to lose.

But fully expect Anavex Life Sciences Corp to be a giant success, for its management (which holds a lot of shares and warrants), for health insurance companies, for retail and institutional owners, and for patients. I still hold that Anavex technologies will have a greater, more positive effect on 21st century medicine than antibiotics did in the 20th century.

Presently, those with moderate understandings and perspectives of Anavex see only a potential for Rett, Parkinson’s, and Alzheimer’s treatments — and for many, very reduced, if at all.

Watch. The Rett results will affirm Anavex sigma-1 receptor agonist efficacy, clearly indicating that restoration of neuron homeostasis will uniquely occur in any number of other central nervous system diseases, too.

But the Anavex story will be much larger; primarily because of prophylactic applications, for both CNS conditions but many others yet to be discovered in humans (already known in lab murines, yet to be announced — lawyers prevent such corporate presentations).

I won’t go into all of that again. Those who’ve read my discussions either agree, or continue with their own perspectives, absent any real understanding of cytological processes.

Well enough. I no longer have anything to contribute to IHub discussions of Anavex Life Sciences Corp. Nothing new or useful has appeared here in the last many weeks. Fact is, none of the clinical trials have started, for whatever reasons. Until they do, and until results appear, deliberate or surreptitious, most of what appears here is useless jabber.

My best wishes to all.